CHF6333 Placebo clinical trials

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

This study is looking at a new inhaler medicine, CHF6333, for people with bronchiectasis. It checks how safe it is and how the body handles it, in healthy people and those with the condition, both after single and repeated doses.